Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Konecny

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Current Opinion in Obstetrics & Gynecology|December 8, 2015
Cyclin-dependent kinase pathways as targets for women's cancer treatmentGottfried E Konecny
Gynecologic Oncology|October 8, 2013
Are ABCB1 (P-glycoprotein) polymorphisms clinically relevant in ovarian cancer? - Finally an Answer!Gottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 19, 2013
Sequencing efforts help to refine the molecular classification of breast cancerGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 18, 2014
The path to personalized medicine in women's cancers: challenges and recent advancesGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 8, 2015
Securing global access to innovations in women's cancer care and controlGottfried E Konecny
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Understanding Exceptional Responses to Poly (ADP-ribose) Polymerase Inhibition in Sporadic Ovarian CancerGottfried E Konecny
The Lancet. Oncology|March 30, 2019
Inhibition of PD-1 and VEGF in microsatellite-stable endometrial cancerGottfried E Konecny
Ebiomedicine|April 14, 2019
Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancerGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 13, 2016
Cancer genomics and clinical practice: how can we close the gap more quickly?Gottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 18, 2012
Emerging strategies for the dual inhibition of HER2-positive breast cancerGottfried E Konecny
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Current Opinion in Obstetrics & Gynecology|December 8, 2015
Cyclin-dependent kinase pathways as targets for women's cancer treatmentGottfried E Konecny
Gynecologic Oncology|October 8, 2013
Are ABCB1 (P-glycoprotein) polymorphisms clinically relevant in ovarian cancer? - Finally an Answer!Gottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 19, 2013
Sequencing efforts help to refine the molecular classification of breast cancerGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 18, 2014
The path to personalized medicine in women's cancers: challenges and recent advancesGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 8, 2015
Securing global access to innovations in women's cancer care and controlGottfried E Konecny
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Understanding Exceptional Responses to Poly (ADP-ribose) Polymerase Inhibition in Sporadic Ovarian CancerGottfried E Konecny
The Lancet. Oncology|March 30, 2019
Inhibition of PD-1 and VEGF in microsatellite-stable endometrial cancerGottfried E Konecny
Ebiomedicine|April 14, 2019
Combining PARP and CDK4/6 inhibitors in MYC driven ovarian cancerGottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 13, 2016
Cancer genomics and clinical practice: how can we close the gap more quickly?Gottfried E Konecny
Current Opinion in Obstetrics & Gynecology|December 18, 2012
Emerging strategies for the dual inhibition of HER2-positive breast cancerGottfried E Konecny
Pageof 16